Chamath Palihapitiya

Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023

Retrieved on: 
Tuesday, January 10, 2023

FRANKLIN, Tenn., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today provides a business update and announces partial guidance for full-year 2023.

Key Points: 
  • FRANKLIN, Tenn., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today provides a business update and announces partial guidance for full-year 2023.
  • “2023 will be a pivotal year for Clover Health and I believe we will prove out the strength of our approach to managing care for Medicare beneficiaries.
  • However, the partial guidance for full-year 2023 we are issuing today highlights the anticipated favorable impact of our ongoing strategy to prioritize profitability”, said Mr. Toy.
  • For full-year 2023, Clover Health issues its partial guidance as follows:
    Insurance revenues are expected to be in the range of $1.15 billion to $1.20 billion in 2023, as compared to our most recently issued 2022 guidance range(1) of $1.0 billion to $1.1 billion.

Clover Health Issues December 2022 Investor Frequently Asked Questions

Retrieved on: 
Tuesday, December 13, 2022

FRANKLIN, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today issued December Investor Frequently Asked Questions on its investor relations website at https://investors.cloverhealth.com/investor-resources/FAQs .

Key Points: 
  • FRANKLIN, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today issued December Investor Frequently Asked Questions on its investor relations website at https://investors.cloverhealth.com/investor-resources/FAQs .
  • Clover may continue to provide updates to Investor Frequently Asked Questions on its investor website.
  • Clover Health (Nasdaq: CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare.
  • Our strategy is underpinned by our proprietary software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes.

The Insurtech Market Is Expected To Grow At A 30% Rate With The Rise In Insurance Claims - By The Business Research Company

Retrieved on: 
Tuesday, December 6, 2022

The rise in the number of hospitalization cases during the Covid-19 pandemic has led to the increase in insurance claims.

Key Points: 
  • The rise in the number of hospitalization cases during the Covid-19 pandemic has led to the increase in insurance claims.
  • According to a study by Digit Insurance, an India-based insurance company, health insurance claims surged over 3.5 times in 2021.
  • Therefore, the increase in insurance claims is expected to drive the growth of the insurtech market during the forecast period.
  • As per the insurtech market research , DXC Technology was the largest competitor in the insurtech market in 2021, with a 4.71% share of the market.

The Insurtech Market Is Expected To Grow At A 30% Rate With The Rise In Insurance Claims - By The Business Research Company

Retrieved on: 
Tuesday, December 6, 2022

The rise in the number of hospitalization cases during the Covid-19 pandemic has led to the increase in insurance claims.

Key Points: 
  • The rise in the number of hospitalization cases during the Covid-19 pandemic has led to the increase in insurance claims.
  • According to a study by Digit Insurance, an India-based insurance company, health insurance claims surged over 3.5 times in 2021.
  • Therefore, the increase in insurance claims is expected to drive the growth of the insurtech market during the forecast period.
  • As per the insurtech market research , DXC Technology was the largest competitor in the insurtech market in 2021, with a 4.71% share of the market.

Dr. Anna Loengard Joins Clover Health Board of Directors

Retrieved on: 
Wednesday, November 30, 2022

FRANKLIN, Tenn., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (Clover, Clover Health or the Company), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Anna Loengard, M.D.

Key Points: 
  • FRANKLIN, Tenn., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (Clover, Clover Health or the Company), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Anna Loengard, M.D.
  • Dr. Loengard is a highly accomplished physician executive with significant experience in both geriatric medicine and value based care models.
  • She most recently served as Chief Medical Officer of AccentCare, an enterprise providing home health, hospice, and private care services across 31 states.
  • Clover Health (Nasdaq: CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare.

Clover Health Reports Third Quarter 2022 Financial Results

Retrieved on: 
Monday, November 7, 2022

"Third quarter financial results were highlighted by strong Insurance MCR performance, outsized revenue growth, and continued moderation of Adjusted SG&A growth," said Clover Health CFO Scott Leffler.

Key Points: 
  • "Third quarter financial results were highlighted by strong Insurance MCR performance, outsized revenue growth, and continued moderation of Adjusted SG&A growth," said Clover Health CFO Scott Leffler.
  • Clover Health's management will host a conference call to discuss its financial results on Monday, November 7, at 5:00 PM Eastern Time.
  • These non-GAAP financial measures are provided to enhance the reader's understanding of Clover Health's past financial performance and our prospects for the future.
  • Clover Health's management team uses these non-GAAP financial measures in assessing Clover Health's performance, as well as in planning and forecasting future periods.

doola Raises $8M to Expand Its Fintech Suite and Democratize Access to the US Financial Ecosystem

Retrieved on: 
Tuesday, November 8, 2022

This sparks a new era for doola as the company focuses on democratizing access to the US financial ecosystem for all.

Key Points: 
  • This sparks a new era for doola as the company focuses on democratizing access to the US financial ecosystem for all.
  • Their combined product suite is uniquely positioned to service the next generation of companies and support them in this market environment.
  • Arjun Mahadevan, CEO, doola, said, doola is not just a formation service - were a fintech company.
  • By providing adjacent financial tools designed to help emerging companies grow more efficiently, doola is the fuel these businesses need.

Clover Health to Present at Credit Suisse 31st Annual Healthcare Conference on November 10, 2022

Retrieved on: 
Thursday, November 3, 2022

FRANKLIN, Tenn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (Clover, Clover Health or the Company), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the Credit Suisse 31st Annual Healthcare Conference on Thursday, November 10, 2022, at 12:10 p.m. Eastern Time.

Key Points: 
  • FRANKLIN, Tenn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (Clover, Clover Health or the Company), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the Credit Suisse 31st Annual Healthcare Conference on Thursday, November 10, 2022, at 12:10 p.m. Eastern Time.
  • A live webcast of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/ .
  • An archived replay of the presentation will be available from the same website for 12 months following the live presentation.
  • Clover Health (Nasdaq: CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare.

Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023

Retrieved on: 
Tuesday, October 11, 2022

FRANKLIN, Tenn., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (Clover, Clover Health or the Company) today announced that for the 2021 measurement year, the Centers for Medicare and Medicaid Services (CMS) has rated its PPO Medicare Advantage (MA) plan at 3.5 stars and increased the rating of its HMO MA plan from 3 stars to 3.5 stars on the Medicare Star Ratings.

Key Points: 
  • FRANKLIN, Tenn., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (Clover, Clover Health or the Company) today announced that for the 2021 measurement year, the Centers for Medicare and Medicaid Services (CMS) has rated its PPO Medicare Advantage (MA) plan at 3.5 stars and increased the rating of its HMO MA plan from 3 stars to 3.5 stars on the Medicare Star Ratings.
  • Our goal is to provide everyone with access to personalized primary care from a physician that they trust, and maintaining our star rating validates our differentiated approach, said Jamie Reynoso, Chief Operating Officer of Clover.
  • Clover Health (Nasdaq: CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare.
  • Through our Insurance line of business, we provide PPO and HMO plans to Medicare Advantage members in several states.

Clover Health to Report Third Quarter 2022 Financial Results on November 7, 2022

Retrieved on: 
Monday, October 10, 2022

FRANKLIN, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (Clover, Clover Health or the Company), a physician enablement company committed to improving health equity for seniors, today announced that it will report third quarter 2022 financial results after market close on Monday, November 7, 2022.

Key Points: 
  • FRANKLIN, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (Clover, Clover Health or the Company), a physician enablement company committed to improving health equity for seniors, today announced that it will report third quarter 2022 financial results after market close on Monday, November 7, 2022.
  • On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Companys business and financial results.
  • Our strategy is underpinned by our proprietary software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes.
  • Through our Insurance line of business, we provide PPO and HMO plans to Medicare Advantage members in several states.